Phalempin, France

André Capron


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of André Capron

Introduction

André Capron is a notable inventor based in Phalempin, France. He has made significant contributions to the field of immunology through his innovative research and inventions. His work primarily focuses on developing vaccines and immune response stimulators.

Latest Patents

One of André Capron's key patents is titled "Bordetella strain expressing the FHA hybrid, liposomes and vaccines." This invention involves a Bordetella strain that is deficient in toxin production and expresses a hybrid protein that includes parts of the filamentous hemagglutinin (FHA) and a heterologous protein. The gene responsible for toxin production has been eliminated or mutated to create an inactive form of the toxin. This strain has potential applications as a vaccine. Additionally, the invention includes liposomes that contain parts of the FHA protein and at least one heterologous protein, which can be used to stimulate immune responses.

Career Highlights

André Capron is affiliated with the Institut Pasteur de Lille, where he conducts his research and development work. His career has been marked by a commitment to advancing vaccine technology and improving public health through innovative solutions.

Collaborations

Throughout his career, André has collaborated with esteemed colleagues such as Nathalie Mielcarek and Camille Locht. These collaborations have further enhanced the impact of his research and inventions in the field of immunology.

Conclusion

André Capron's contributions to vaccine development and immune response stimulation highlight his role as a significant inventor in the field of immunology. His innovative work continues to influence the advancement of medical science and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…